237 related articles for article (PubMed ID: 30913463)
1. Tumor Size Improves the Accuracy of the Prognostic Prediction of Lymph Node-Negative Gastric Cancer.
Liang Y; Liu L; Xie X; Xia L; Meng J; Xu R; He D
J Surg Res; 2019 Aug; 240():89-96. PubMed ID: 30913463
[TBL] [Abstract][Full Text] [Related]
2. Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
Jiang N; Deng JY; Ding XW; Liu Y; Liang H
Eur J Surg Oncol; 2015 Mar; 41(3):315-22. PubMed ID: 25601610
[TBL] [Abstract][Full Text] [Related]
3. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
4. A new predictive model combined of tumor size, lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer.
Zhao LY; Chen XL; Wang YG; Xin Y; Zhang WH; Wang YS; Chen XZ; Yang K; Liu K; Xue L; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Nov; 7(44):72300-72310. PubMed ID: 27509175
[TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Wang J; Yu JC; Kang WM; Ma ZQ
J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
[TBL] [Abstract][Full Text] [Related]
7. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
Gu P; Deng J; Sun Z; Wang Z; Wang W; Liang H; Xu H; Zhou Z
Surg Today; 2021 Jan; 51(1):101-110. PubMed ID: 32754844
[TBL] [Abstract][Full Text] [Related]
8. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
10. Tumor size as a recommendable variable for accuracy of the prognostic prediction of gastric cancer: a retrospective analysis of 1,521 patients.
Deng J; Zhang R; Pan Y; Ding X; Cai M; Liu Y; Liu H; Bao T; Jiao X; Hao X; Liang H
Ann Surg Oncol; 2015 Feb; 22(2):565-72. PubMed ID: 25155400
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
Wu XJ; Miao RL; Li ZY; Bu ZD; Zhang LH; Wu AW; Zong XL; Li SX; Shan F; Ji X; Ren H; Ji JF
Eur J Surg Oncol; 2015 Jul; 41(7):927-33. PubMed ID: 25913059
[TBL] [Abstract][Full Text] [Related]
12. Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients.
Deng J; Yamashita H; Seto Y; Liang H
Ann Surg Oncol; 2017 Mar; 24(3):745-753. PubMed ID: 27770340
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
16. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
[TBL] [Abstract][Full Text] [Related]
18. Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer.
Deng J; Zhang R; Wu L; Zhang L; Wang X; Liu Y; Hao X; Liang H
Ann Surg Oncol; 2015 Apr; 22(4):1258-66. PubMed ID: 25319573
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution.
Bruixola G; Segura Á; Díaz-Beveridge R; Caballero J; Bennis MH; Palomar L; Giménez A; Mingol F; García-Mora C; Aparicio J
Tumori; 2015; 101(5):517-23. PubMed ID: 26045120
[TBL] [Abstract][Full Text] [Related]
20. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
